2020, May 16-18: Dermatopathology in the Desert: Dodging Bullets in the Dermatopathology Wilderness
May 16-18, 2020 - Palm Springs, California
Differentiating neoplastic from non-neoplastic disorders is one of the most difficult diagnostic challenges in pathology. Accurate diagnosis is paramount to initiate the appropriate treatment. It requires specific skills which often include at least some degree of clinical knowledge, awareness of the broad morphologic range and familiarity with ancillary tests. Errors in the interpretation of skin biopsies, especially in relation to melanocytic tumours, are among the most frequent causes for litigation in surgical biopsy and can lead to unfavorable patient outcomes. There are numerous pitfalls that diagnostic pathologists need to be aware of, including lack of relevant clinical information, sampling error and the wide morphologic spectrum of both inflammatory and neoplastic disorders, often showing overlapping findings and only subtle differentiating features. This special course will elevate your knowledge and polish your diagnostic skills as you interact with experts in a uniquely intimate mentoring environment.
- Understand the wide morphologic spectrum of cutaneous tumors and associated diagnostic challenges
- Learn about recent developments in dermatopathology
- Learn how to integrate clinical information and ancillary tests to achieve a better and more precise diagnosis
- Understand the appropriate use and limitations of immunofluorescence testing in dermatopathology
- Thomas Brenn, MD, PhD, FRCPath
University of Calgary, Cumming School of Medicine
- Jaime Eduardo Calonje, MD, DipRCPath
St. John’s Institute of Dermatology, St. Thomas Hospital
- Julia S. Lehman, MD
- Iwei Yeh, MD, PhD
University of California San Francisco (UCSF)
CONTINUING MEDICAL EDUCATION AND CONTINUING CERTIFICATION
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC).
Physicians can earn a maximum of 15.75 SAM/Part II credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
Cancellations will be assessed an administrative charge of 25% of the total registration fee. There will be no refunds for cancellations within 14 days of the event. The Academy is not responsible for travel expenses incurred as a result of an event cancellation.